Corporate News: Orthocell Ltd (OCC.AX)
Trading performance
Orthocell shares fell 7.69 % during the 24‑hour period ending 07:07 AM Central Europe on Thursday 22 January 2027.
The current trading price is AUD 0.53 per share on major Australian exchanges.
Volume traded in the last 24 hours was approximately AUD 754.6 k.
The company’s market capitalization stands at AUD 177.1 m.
Since the close of the previous month, the share price has declined 16.08 %.
The 200‑day simple moving average is AUD 0.81.
The 52‑week high was AUD 1.30 on 24 October 2025; the 52‑week low was AUD 0.60 on 21 October 2026.
Share supply
Outstanding shares: 295.1 million.
Comparative performance (last 24 hours)
| Ticker | % change | Current price (AUD) | Market cap (AUD m) | P/E ratio |
|---|---|---|---|---|
| ARR.AX | 0 % | 0.36 | 203.9 | – |
| BIS.AX | +6.12 % | 4.13 | 201.0 | 12.14 |
| HUM.AX | 0 % | 0.42 | 209.6 | 13.23 |
| VFY.AX | –4 % | 2.70 | 209.6 | – |
| MYX.AX | 0 % | 2.53 | 208.0 | 9.41 |
- Company background
- Orthocell Ltd is a biotechnology development firm listed on the ASX All Markets.
- The company focuses on biological therapies for tendon and ligament repair and regeneration within the orthopaedic health care sector.
- Corporate website: www.orthocell.com.au .
The information above reflects the latest market data available as of the specified trading period.
